Luisa Hector
Stock Analyst at Berenberg Bank
(3.74)
# 2,018
Out of 4,501 analysts
289
Total ratings
59%
Success rate
5.8%
Average return
Main Sectors:
Stocks Rated by Luisa Hector
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MRK Merck & Co. | Maintained: Hold | $115 → $125 | $125.07 | -0.06% | 34 | Jun 22, 2026 | |
| ABBV AbbVie | Maintained: Buy | $275 | $249.91 | +10.04% | 18 | May 8, 2026 | |
| SWX: ROP Roche Holding AG | Maintained: Hold | CHF 340.00 | $339.80 | +0.06% | 52 | May 8, 2026 | |
| EPA: SAN Sanofi | Maintained: Buy | €105.00 | $76.78 | +36.75% | 50 | May 6, 2026 | |
| LON: AZN AstraZeneca PLC | Rated: Buy | 17,000p | $13,236.00 | +28.44% | 69 | Mar 16, 2026 | |
| SWX: NOVN Novartis AG | Rated: Hold | CHF 92.00 → CHF 110.00 | $125.62 | -12.43% | 4 | Mar 6, 2026 | |
| LON: BTRW Barratt Redrow plc | Maintained: Hold | 414p | $282.40 | +46.60% | 1 | Feb 11, 2026 | |
| LON: 0QIU Novo Nordisk A/S | Maintained: Buy | kr 400.00 → kr 415.00 | $320.55 | +29.46% | 7 | Jan 16, 2026 | |
| LON: GSK GSK plc | Maintained: Hold | 1,660p | $1,976.50 | -16.01% | 7 | Jan 6, 2026 | |
| SNY Sanofi | Maintained: Buy | $63 → $67 | $43.90 | n/a | 11 | May 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $55 → $60 | $57.94 | n/a | 18 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $484.60 | n/a | 1 | Feb 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | €197.00 | $140.90 | n/a | 13 | Feb 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $43 | $24.25 | n/a | 1 | Jun 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | €78.61 | $51.82 | n/a | 1 | Sep 11, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $14.44 | n/a | 2 | Sep 15, 2016 |
Merck & Co.
Jun 22, 2026
Maintained: Hold
Price Target: $115 → $125
Current: $125.07
Upside: -0.06%
AbbVie
May 8, 2026
Maintained: Buy
Price Target: $275
Current: $249.91
Upside: +10.04%
Roche Holding AG
May 8, 2026
Maintained: Hold
Price Target: CHF 340.00
Current: $339.80
Upside: +0.06%
Sanofi
May 6, 2026
Maintained: Buy
Price Target: €105.00
Current: $76.78
Upside: +36.75%
AstraZeneca PLC
Mar 16, 2026
Rated: Buy
Price Target: 17,000p
Current: $13,236.00
Upside: +28.44%
Novartis AG
Mar 6, 2026
Rated: Hold
Price Target: CHF 92.00 → CHF 110.00
Current: $125.62
Upside: -12.43%
Barratt Redrow plc
Feb 11, 2026
Maintained: Hold
Price Target: 414p
Current: $282.40
Upside: +46.60%
Novo Nordisk A/S
Jan 16, 2026
Maintained: Buy
Price Target: kr 400.00 → kr 415.00
Current: $320.55
Upside: +29.46%
GSK plc
Jan 6, 2026
Maintained: Hold
Price Target: 1,660p
Current: $1,976.50
Upside: -16.01%
Sanofi
May 16, 2025
Maintained: Buy
Price Target: $63 → $67
Current: $43.90
Upside: n/a
Dec 10, 2024
Maintained: Hold
Price Target: $55 → $60
Current: $57.94
Upside: n/a
Feb 28, 2024
Upgraded: Buy
Price Target: n/a
Current: $484.60
Upside: n/a
Feb 10, 2022
Maintained: Hold
Price Target: €197.00
Current: $140.90
Upside: n/a
Jun 14, 2021
Maintained: Hold
Price Target: $43
Current: $24.25
Upside: n/a
Sep 11, 2018
Maintained: Hold
Price Target: €78.61
Current: $51.82
Upside: n/a
Sep 15, 2016
Reiterated: Hold
Price Target: n/a
Current: $14.44
Upside: n/a